World Health Organization. Childhood overweight and obesity. Accessed at www.who.int/dietphysicalactivity/childhood/en on February22, 2018.
2.
DesprésJP, LemieuxI. Abdominal obesity and metabolic syndrome. Nature, 2006; 444:881–887.
3.
MokhaJS, SrinivasanSR, DasmahapatraP, et al.Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Bogalusa Heart Study. BMC Pediatr, 2010; 10:73.
4.
GrundySM, BrewerHBJr., CleemanJI, et al.Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 2004; 109:433–438.
5.
Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.
6.
GrundySM, CleemanJI, DanielsSR, et al.Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112:2735–2752.
7.
DesprésJP, LemieuxI, BergeronJ, et al.Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol, 2008; 28:1039–1049.
8.
de FerrantiSD, GauvreauK, LudwigDS, et al.Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation, 2004; 110:2494–2497.
9.
WeissR, DziuraJ, BurgertTS, et al.Obesity and the metabolic syndrome in children and adolescents. N Engl J Med, 2004; 350:2362–2374.
10.
ZimmetP, AlbertiG, KaufmanF, et al.The metabolic syndrome in children and adolescents. Lancet, 2007; 369:2059–2061.
11.
DeBoerMD, GurkaMJ. Clinical utility of metabolic syndrome severity scores: Considerations for practitioners. Diabetes Metab Syndr Obes, 2017; 10:65–72.
12.
GurkaMJ, IceCL, SunSS, et al.A confirmatory factor analysis of the metabolic syndrome in adolescents: An examination of sex and racial/ethnic differences. Cardiovasc Diabetol, 2012; 11:128.
13.
GurkaMJ, LillyCL, OliverMN, et al.An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: A confirmatory factor analysis and a resulting continuous severity score. Metabolism, 2014; 63:218–225.
14.
DeBoerMD, GurkaMJ, WooJG, et al.Severity of metabolic syndrome as a predictor of cardiovascular disease between childhood and adulthood: The Princeton Lipid Research Cohort Study. J Am Coll Cardiol, 2015; 66:755–757.
15.
DeBoerMD, GurkaMJ, WooJG, et al.Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: The Princeton Lipid Research Cohort Study. Diabetologia, 2015; 58:2745–2752.
16.
WangLX, FilippSL, UrbinaEM, et al.Longitudinal associations of metabolic syndrome severity between childhood and young-adulthood: The Bogalusa Heart Study. Metab Syndr Relat Disord, 2018; 16:208–214.
17.
BaoW, SrinivasanSR, WattigneyWA, et al.Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med, 1994; 154:1842–1847.
18.
EisenmannJC, WelkGJ, WickelEE, et al.Stability of variables associated with the metabolic syndrome from adolescence to adulthood: The Aerobics Center Longitudinal Study. Am J Hum Biol, 2004; 16:690–696.
19.
BerensonGS, SrinivasanSR, BaoW, et al.Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med, 1998; 338:1650–1656.
20.
BorelAL, NazareJA, BaillotA, et al.Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: Contribution of improved cardiorespiratory fitness vs. weight loss. Am J Physiol Endocrinol Metab, 2017; 312:E273–E281.
21.
KnowlerWC, Barrett-ConnorE, FowlerSE, et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002; 346:393–403.
